Summary & Overview
HCPCS Level II L8609: Artificial Cornea
HCPCS Level II code L8609 identifies an artificial cornea prosthetic device used in complex corneal replacement procedures. Artificial corneas are clinically significant as a vision-restoring option for patients with severe corneal disease or failed grafts who are not candidates for standard penetrating or lamellar keratoplasty. Nationally, device-level coding like L8609 is important for tracking utilization, device costs, and access to advanced ophthalmic care.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes how these payers typically handle coverage determinations for high-cost ophthalmic prostheses, administrative considerations tied to device billing, and common sites of service where implantation occurs.
Readers will find concise benchmarks and coverage context, an overview of billing and documentation considerations relevant to hospital outpatient departments and ambulatory surgical centers, and clinical context describing when an artificial cornea is indicated. Data not available in the input is noted where applicable, and the report focuses on national payer practices and policy-relevant observations rather than state-specific rules.
Billing Code Overview
HCPCS Level II code L8609 denotes an artificial cornea. This item represents a prosthetic device used to replace or augment a damaged or diseased cornea to restore vision when conventional corneal transplantation or medical therapy is not appropriate.
-
Service type: Ophthalmic prosthetic device
-
Typical site of service: Hospital outpatient department, ambulatory surgical center, or specialty ophthalmology clinic where device implantation or device-related surgical procedures are performed.
Clinical & Coding Specifications
Clinical Context
A 67-year-old patient with end-stage corneal disease from multiple prior graft failures and severe stromal scarring is evaluated by a cornea specialist for visual rehabilitation. After multidisciplinary review, the patient is scheduled for implantation of an artificial cornea (L8609) — a keratoprosthesis — under monitored anesthesia care or general anesthesia in an ambulatory surgery center or hospital operating room. Preoperative workflow includes ophthalmic examination, ocular surface optimization, systemic evaluation for anesthesia risk, and informed consent documenting goals and risks. Intraoperative workflow includes sterile preparation, placement of the keratoprosthesis with suturing or fixation to residual host tissue, possible concurrent procedures (e.g., eyelid repair, glaucoma shunt placement), and documentation of device model and lot number. Postoperative care includes immediate recovery monitoring, short-term intensive topical antibiotics and steroids, serial postoperative clinic visits for pressure checks and graft/device integration, and coordination with durable medical equipment/implant tracking for the artificial cornea device.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the surgeon's professional service separate from facility or device charge. |